Publications

Detailed Information

Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia

Cited 32 time in Web of Science Cited 38 time in Scopus
Authors

Kang, C-I; Kim, S-H; Park, W B; Lee, K-D; Kim, H-B; Kim, E-C; Oh, M-D; Choe, K-W

Issue Date
2005-04-12
Publisher
Wiley-Blackwell
Citation
Clin Microbiol Infect. 2005 May;11(5):415-8.
Keywords
AdultAgedAged, 80 and overAnti-Bacterial Agents/therapeutic useBacteremia/drug therapy/*epidemiology/mortality/pathologyCommunity-Acquired Infections/drug therapy/*epidemiology/pathologyComorbidityFemaleHematologic Neoplasms/pathologyHospitalsHumansKorea/epidemiologyMaleMiddle AgedNeoplasms/pathologyNeutropenia/epidemiology/pathologyPseudomonas Infections/drug therapy/*epidemiology/pathologyRetrospective StudiesRisk FactorsShock, Septic/pathologyPseudomonas aeruginosa
Abstract
Cases of community-acquired Pseudomonas aeruginosa bacteraemia (n = 39) that occurred at a tertiary-care hospital during a 5-year period were analysed retrospectively. The commonest underlying diseases were solid tumour (41%) and haematological malignancy (18%). Most (44%) of the patients were neutropenic, and 39% had septic shock at initial presentation. The 30-day attributable mortality rate was 39%. Two previously healthy patients were identified with fatal P. aeruginosa pneumonia with bacteraemia. P. aeruginosa bacteraemia is a fatal infection that should be considered in the differential diagnosis of patients presenting from the community with rapidly progressive sepsis.
ISSN
1198-743X (Print)
Language
English
URI
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15819873

https://hdl.handle.net/10371/23387
DOI
https://doi.org/10.1111/j.1469-0691.2005.01102.x
Files in This Item:
There are no files associated with this item.
Appears in Collections:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share